This complaint has been reported during a literature review performed by the post market surveillance group.No product identification is possible.Based on the investigation results, no definitive relation could be established between the product and the reported failure adverse consequence.The reported event could not be confirmed, since the device was not returned for evaluation and no other additional information will be provided.If further relevant information becomes available, the investigation will be reevaluated and resubmitted accordingly.Device disposition is unknown.
|
The manufacturer became aware of a post-market clinical follow-up (pmcf) from (b)(6).The title of this report is ¿prospective and a retrospective evaluation of the mid- to long-term outcomes of subjects treated with the moovistm prosthesis¿ which is associated with the stryker moovis prosthesis.Within that publication, post- operative complications/ adverse events were reported which occurred between 2013 and 2016.It was not possible to ascertain specific device catalog or patient information from the report, a review of the complaint handling database, however, revealed that the events have not been reported by the hospital or by the author of the publication, therefore 9 complaints were initiated retrospectively for different adverse events mentioned in the report.This product inquiry addresses neurodystrophy.1 out of 4 cases.The pmcf report states, ¿4 patients were diagnosed with neurodystrophy in post op, exhibiting moderate forms of this chronic pain syndrome.All the involved patients recovered from this neurodystrophty without significant sequelae.¿.
|